Amobarbital
- Generic Name
- Amobarbital
- Drug Type
- Small Molecule
- Chemical Formula
- C11H18N2O3
- CAS Number
- 57-43-2
- Unique Ingredient Identifier
- GWH6IJ239E
- Background
A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
- Indication
中效催眠药，主要用于催眠、镇静、抗惊厥以及麻醉前给药。
Amobarbital and Cardiopulmonary Bypass
Not Applicable
Recruiting
- Conditions
- Cardiopulmonary Bypass
- Interventions
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT06757868
- Locations
- 🇨🇳
Tongji hospital, Wuhan, Hubei, China
Effect of Amobarbital Sodium Combined With Low-dose Propofol on Hemodynamics During Induction and Perioperative Adverse Reactions
Phase 4
Not yet recruiting
- Conditions
- Hemodynamics InstabilityAmobarbital Sodium
- Interventions
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 96
- Registration Number
- NCT06385756
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath